Operating Lease, Right-of-Use Asset of Processa Pharmaceuticals, Inc. from 02 Jan 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Processa Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 02 Jan 2019 to 30 Jun 2025.
  • Processa Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $24,318.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Processa Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $24,318 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $47,737 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $70,677 -$75,380 -52% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q4 2023 $146,057 -$81,530 -36% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $167,035 -$79,944 -32% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $187,605 +$158,715 +549% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $207,787 +$156,165 +303% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $227,587 +$153,406 +207% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 $246,979 +$151,045 +157% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $28,890 -$88,346 -75% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $51,622 -$86,486 -63% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $74,181 -$84,377 -53% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $95,934 -$63,265 -40% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $117,236 -$62,355 -35% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $138,108 -$61,418 -31% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $158,558 -$60,516 -28% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $159,199 -$78,987 -33% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $179,591 -$77,325 -30% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $199,526 -$75,725 -28% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 $219,074 -$74,124 -25% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 $238,186 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $256,916 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $275,251 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 $293,198 02 Jan 2019 10-Q 14 Aug 2019 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.